These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38411437)

  • 21. Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls.
    Schmidt J; Brännström M; Landin-Wilhelmsen K; Dahlgren E
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2178-85. PubMed ID: 21508129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts.
    Farland LV; Stern JE; Liu CL; Cabral HJ; Coddington CC; Diop H; Dukhovny D; Hwang S; Missmer SA
    Hum Reprod; 2022 Oct; 37(11):2690-2699. PubMed ID: 36149255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Association of Polycystic Ovary Syndrome and Gestational Hypertensive Disorders in a Diverse Community-Based Cohort.
    Schneider D; Gonzalez JR; Yamamoto M; Yang J; Lo JC
    J Pregnancy; 2019; 2019():9847057. PubMed ID: 30693108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Polycystic Ovary Syndrome on Silent Coronary Artery Disease and Cardiovascular Events; A Long-term Population-based Cohort Study.
    Mahboobifard F; Rahmati M; Niknam A; Rojhani E; Momenan AA; Azizi F; Ramezani Tehrani F
    Arch Med Res; 2022 Apr; 53(3):312-322. PubMed ID: 34823887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome.
    Ehsani B; Moslehi N; Mirmiran P; Ramezani Tehrani F; Tahmasebinejad Z; Azizi F
    Clin Nutr; 2016 Oct; 35(5):1181-7. PubMed ID: 26699405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization.
    Sterling L; Liu J; Okun N; Sakhuja A; Sierra S; Greenblatt E
    Fertil Steril; 2016 Mar; 105(3):791-797.e2. PubMed ID: 26654973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The risk of chronic kidney disease among women with polycystic ovary syndrome: A long-term population-based cohort study.
    Behboudi-Gandevani S; Amiri M; Cheraghi L; Amanollahi Soudmand S; Azizi F; Ramezani Tehrani F
    Clin Endocrinol (Oxf); 2020 Nov; 93(5):590-597. PubMed ID: 32654166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation.
    Mostinckx L; Segers I; Belva F; Buyl R; Santos-Ribeiro S; Blockeel C; Smitz J; Anckaert E; Tournaye H; De Vos M
    Hum Reprod; 2019 Aug; 34(8):1595-1607. PubMed ID: 31347678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecundity among women with polycystic ovary syndrome (PCOS)-a population-based study.
    Persson S; Elenis E; Turkmen S; Kramer MS; Yong EL; Sundström-Poromaa I
    Hum Reprod; 2019 Oct; 34(10):2052-2060. PubMed ID: 31504532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes.
    Mumm H; Jensen DM; Sørensen JA; Andersen LL; Ravn P; Andersen M; Glintborg D
    Acta Obstet Gynecol Scand; 2015 Feb; 94(2):204-11. PubMed ID: 25417943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of polycystic ovary syndrome in women with type 2 diabetes in Kerman, Iran.
    Mirzaei F; Kazemi N
    Metab Syndr Relat Disord; 2008 Sep; 6(3):215-7. PubMed ID: 18710333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
    J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BMI in childhood and adolescence is associated with impaired reproductive function-a population-based cohort study from birth to age 50 years.
    Laru J; Nedelec R; Koivuaho E; Ojaniemi M; Järvelin MR; Tapanainen JS; Franks S; Tolvanen M; Piltonen TT; Sebert S; Morin-Papunen L
    Hum Reprod; 2021 Oct; 36(11):2948-2961. PubMed ID: 34364312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between empirically derived dietary patterns and polycystic ovary syndrome: A case-control study.
    Panjeshahin A; Salehi-Abargouei A; Anari AG; Mohammadi M; Hosseinzadeh M
    Nutrition; 2020; 79-80():110987. PubMed ID: 32947130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening method.
    Lerchbaum E; Schwetz V; Giuliani A; Obermayer-Pietsch B
    Hum Reprod; 2013 Sep; 28(9):2537-44. PubMed ID: 23756702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women's Health.
    Joham AE; Boyle JA; Ranasinha S; Zoungas S; Teede HJ
    Hum Reprod; 2014 Apr; 29(4):802-8. PubMed ID: 24549213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies.
    Mills G; Badeghiesh A; Suarthana E; Baghlaf H; Dahan MH
    Hum Reprod; 2020 Jul; 35(7):1666-1674. PubMed ID: 32535629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of ageing and menopause in women with polycystic ovary syndrome.
    Helvaci N; Yildiz BO
    Clin Endocrinol (Oxf); 2022 Sep; 97(3):371-382. PubMed ID: 34288042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.